Published in Cardiovascular Device Liability Week, February 4th, 2007
"We assessed the accuracy of this qualitative central hemodynamic evaluation obtained by TEE at the bedside....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.